DERMAPHARM
DERMAPHARM
Share · DE000A2GS5D8 · A2GS5D (XFRA)
Overview Financial Indicators
35,95 EUR
-2,44 % -0,90 EUR
Frankfurt (XETR) · Current prices and charts at MoneyPeak
10.06.2025 15:35

Current Prices from DERMAPHARM

ExchangeTickerCurrencyLast TradePriceDaily Change
XETR: XETRA
XETRA
DMP.DE
EUR
10.06.2025 15:35
35,95 EUR
36,85 EUR
-2,44 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
-2,44 % 3,75 % -9,10 % -8,41 % -5,89 % -4,26 % -18,52 %

Company Profile for DERMAPHARM Share

Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription natural remedies, and other healthcare products. It also offers healthcare products in the areas of vitamins, minerals, food supplements, dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology primarily under the Dekristol, Dekristolvit, Allergovit, and Tromcardin brands. In addition, the company provides medical devices under the bite away and Herpotherm names; Momekort, a nasal spray used to treat allergy symptoms; and Azedil, a nasal spray or eye drop. Further, it imports originator pharmaceuticals under the axicorp brand; and offers herbal extracts and natural active ingredients for phytopharmaceuticals, nutraceuticals, and cosmetics. It serves pharmaceutical wholesalers, pharmacies, hospitals, and health food stores. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-Aktiengesellschaft.

Invested Funds

The following funds have invested in: DERMAPHARM invested:

Fund
iShares MSCI EMU Small Cap UCITS ETF EUR (Acc)
Vol. in million
2.268,55
Percentage (%)
0,26 %

Company Data

Name DERMAPHARM
Company Dermapharm Holding SE
Website https://www.dermapharm.de
Primary Exchange XFRA Frankfurt
WKN A2GS5D
ISIN DE000A2GS5D8
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Dr. Hans-Georg Feldmeier
Market Capitalization 2 Mrd.
Country Germany
Currency EUR
Employees 3,6 T
Address Lil-Dagover-Ring 7, 82031 Grünwald
IPO Date 2018-04-12
Dividends from 'DERMAPHARM'
Ex-Date Dividend per Share
28.06.2024 0,88 EUR
06.06.2024 0,88 EUR
15.06.2023 1,05 EUR
02.06.2022 2,17 EUR
24.06.2021 0,88 EUR
18.06.2020 0,80 EUR
05.06.2019 0,77 EUR

Ticker Symbols

Name Symbol
Frankfurt DMP.F
XETRA DMP.DE

More Shares

Investors who DERMAPHARM hold also have the following shares in their portfolio:
ADVANCED MICRO DEVICES INC
ADVANCED MICRO DEVICES INC Share
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Share
APPLE INC
APPLE INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
DEKA-EUROPASELECT CF
DEKA-EUROPASELECT CF Fund
JOHNSON & JOHNSON
JOHNSON & JOHNSON Share
MEADOWHALL FINANCE PLC CLS C1 FLTG RTE BDS 12/07/37 £ (BR)
MEADOWHALL FINANCE PLC CLS C1 FLTG RTE BDS 12/07/37 £ (BR) Bond
NVIDIA CORP
NVIDIA CORP Share
PROCTER GAMBLE CORP
PROCTER GAMBLE CORP Share
ProShares UltraShort Consumer Discretionary
ProShares UltraShort Consumer Discretionary ETF
QUALCOMM INC
QUALCOMM INC Share
RF INDUSTRIES, LTD
RF INDUSTRIES, LTD Share
TESLA INC
TESLA INC Share
WALT DISNEY INC
WALT DISNEY INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025